Course Provider
ATMA Journey Centers is an Alberta-based Canadian pioneer in psychedelic-assisted therapy, operating clinically supervised locations across Canada while offering comprehensive psychedelic-assisted therapy training programs (ATMA CENA) covering psilocybin, MDMA, and ketamine for healthcare professionals. With 740+ training alumni and 800+ community members, ATMA also operates a clinic network partnership program and Phase II psilocybin clinical trials with Health Canada approval.
ATMA Journey sits in the clinician-facing end of the psychedelic education field, with a strong Alberta footprint and a clear link to licensed care. Its strongest fit is for registered health professionals who want structured, practice-oriented training and a pathway into regulated psychedelic services rather than a purely introductory public course. The line-up also has unusual credibility from its clinical-trial involvement and its placement within a broader service network, though the public-facing materials do not clearly present a single, simple price or a fully standardised accreditation story.
Best for licensed clinicians, therapists, social workers and other health professionals who want psychedelic-assisted therapy training grounded in regulated Canadian practice. It also suits practitioners looking for a pathway into clinic-based work or research-linked clinical settings.
ATMA’s starting course is described as accessible to any mental health or wellness professional. For clinical-trial participation, ATMA says applicants must have completed an approved psychedelic-assisted therapy training programme, and its trial call-out specifically references frontline mental healthcare professionals and equivalent training.
ATMA CENA is described by the Alberta Nurses Association as a CPA Approved CE Sponsor Program, and ATMA says its Foundations course earns 14 CE credits upon completion. ATMA CENA also states that its clinics are licensed by Alberta Health and accredited through the College of Physicians and Surgeons.
ATMA does not publish a single programme price across its training offer on the main course page. One public guidance document for its treatment services shows deposits and care-pathway charges for clinical services, but not a clean tuition table for the training programme itself.
Learners are positioned to gain foundational knowledge in the history, science, ethics and clinical application of psychedelic-assisted therapy, followed by advanced pathway-specific training. The programme also points towards CE credit recognition and, for suitable graduates, possible contribution to ATMA’s clinical-trial staffing and clinic ecosystem.
Linked Courses
2
Active Listings
1
Primary Formats
Hybrid, Live Classes
Programs linked directly to this provider in the Blossom course dataset.
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
Next cohort: Jul 13, 2026
By Atma Journey
The Introduction to Psychedelic-assisted Therapy is a continuing education credited training course designed for practising psychologists, psychiatrists, and other medical professionals. The course is a prerequisite for the ATMA Advanced Psychedelic-assisted Therapy (PaT) Certification Program, and
Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.